The Hunter-8 Scale Prehospital Triage Workflow for Identification of Large Vessel Occlusion and Brain Haemorrhage.


Journal

Prehospital emergency care
ISSN: 1545-0066
Titre abrégé: Prehosp Emerg Care
Pays: England
ID NLM: 9703530

Informations de publication

Date de publication:
2023
Historique:
medline: 7 7 2023
pubmed: 3 9 2022
entrez: 2 9 2022
Statut: ppublish

Résumé

The Hunter-8 prehospital stroke scale predicts large vessel occlusion in hyperacute ischemic stroke patients (LVO) at hospital admission. We wished to test its performance in the hands of paramedics as part of a prehospital triage algorithm. We aimed to determine (a) the proportion of patients identified by the Hunter-8 algorithm, receiving reperfusion therapies, (b) whether a call to stroke team improved this, and (c) performance for LVO detection using an expanded LVO definition. A prehospital workflow combining pre-morbid functional status, time from symptom onset, and the Hunter-8 scale was implemented from July 2019. A telephone call to the stroke team was prompted for potential treatment candidates. Classic LVO was defined as a proximal middle cerebral artery (MCA-M1), terminal internal carotid artery, or tandem occlusion. Extended LVO added proximal MCA-M2 and basilar occlusions. From July 2019 to April 2021, there were 363 Hunter-8 activations, 320 analyzed: 181 (56.6%) had confirmed ischemic strokes, 13 (4.1%) transient ischemic attack, 91 (28.5%) stroke mimics, and 35 (10.9%) intracranial hemorrhage. Fifty-two patients (16.3%) received reperfusion therapies, 35 with Hunter-8 ≥ 8. The stroke doctor changed the final destination for 76 patients (23.7%), and five received reperfusion therapies. The AUCs for classic and extended LVO were 0.73 (95% CI 0.66-0.79) and 0.72 (95% CI 0.65-0.77), respectively. The Hunter-8 workflow resulted in 28.7% of confirmed ischemic stroke patients receiving reperfusion therapies, with no secondary transfers to the comprehensive stroke center. The role of communication with stroke team needs to be further explored.

Identifiants

pubmed: 36053543
doi: 10.1080/10903127.2022.2120134
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

623-629

Auteurs

C Garcia-Esperon (C)

Department of Neurology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.
College of Health, Medicine, and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.
Hunter Medical Research Institute, Newcastle, New South Wales, Australia.

C Ostman (C)

Department of Neurology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.
College of Health, Medicine, and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.

F R Walker (FR)

College of Health, Medicine, and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.
Hunter Medical Research Institute, Newcastle, New South Wales, Australia.

B L A Chew (BLA)

Department of Neurology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.

S Edwards (S)

New South Wales Ambulance, Rozelle, New South Wales, Australia.

J Emery (J)

New South Wales Ambulance, Rozelle, New South Wales, Australia.

J Bendall (J)

Department of Neurology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.
New South Wales Ambulance, Rozelle, New South Wales, Australia.

K Alanati (K)

Department of Neurology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.

S Dunkerton (S)

Department of Neurology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.

R Starling de Barros (R)

Department of Neurology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.

M Amin (M)

Department of Neurology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.

S Gangadharan (S)

Department of Neurology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.

T Lillicrap (T)

Hunter Medical Research Institute, Newcastle, New South Wales, Australia.

M Parsons (M)

College of Health, Medicine, and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.
Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
Department of Neurology, University of New South Wales South Western Sydney Clinical School, Ingham Institute for Applied Medical Research, Liverpool Hospital, Sydney, New South Wales, Australia.

C R Levi (CR)

Department of Neurology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.
College of Health, Medicine, and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.
Hunter Medical Research Institute, Newcastle, New South Wales, Australia.

N J Spratt (NJ)

Department of Neurology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.
College of Health, Medicine, and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.
Hunter Medical Research Institute, Newcastle, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH